Takeda Pharmaceutical Company Limited Proceeds From Sales Of Interests In Associates
Takeda Pharmaceutical Company Limited (TAK) reported Proceeds From Sales Of Interests In Associates of JPY 57.69 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Cash Flow › Investing Activities
ifrs-full:ProceedsFromSalesOfInterestsInAssociates · last filed 2025-06-25
| Period end | Proceeds From Sales Of Interests In Associates 12 month |
|---|---|
| 2025-03-31 | 57.69B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 0.00 JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 0.00 JPY 20-F · filed 2025-06-25 |